Literature DB >> 22043433

Native valve endocarditis caused by coagulase negative staphylococci; an appeal to start outpatient antimicrobial therapy: an unusual case report.

Nada Al-Tamtami, Jalila Al-Lawati, Seif Al-Abri.   

Abstract

Coagulase negative staphylococci (CNS) were a rare cause of native valve endocarditis. However, they are emerging as an important cause of native valve endocarditis (NVE) in both community and healthcare settings. We describe a 64 yrs. old male who developed mitral valve endocarditis caused by coagulase negative staphylococci. There were no predisposing conditions or underlying cardiac disease that could have been the risk factor for the development of native valve infection. The patient had good recovery after six weeks of treatment with anti-staphylococcal antibiotics.

Entities:  

Keywords:  CoNS; Coagulase negative staphylococcus; NVE; Native valve endocarditis; OPAT; Outpatient antimicrobial therapy

Year:  2011        PMID: 22043433      PMCID: PMC3191720          DOI: 10.5001/omj.2011.65

Source DB:  PubMed          Journal:  Oman Med J        ISSN: 1999-768X


  7 in total

1.  Practice guidelines for outpatient parenteral antimicrobial therapy. IDSA guidelines.

Authors:  Alan D Tice; Susan J Rehm; Joseph R Dalovisio; John S Bradley; Lawrence P Martinelli; Donald R Graham; R Brooks Gainer; Mark J Kunkel; Robert W Yancey; David N Williams
Journal:  Clin Infect Dis       Date:  2004-05-26       Impact factor: 9.079

2.  Increase in native valve endocarditis caused by coagulase negative staphylococci: an Anglo-French clinical and microbiological study.

Authors:  J Etienne; S J Eykyn
Journal:  Br Heart J       Date:  1990-12

3.  Emergence of coagulase-negative staphylococci as a cause of native valve endocarditis.

Authors:  Vivian H Chu; Christopher W Woods; Jose M Miro; Bruno Hoen; Christopher H Cabell; Paul A Pappas; Jerome Federspiel; Eugene Athan; Martin E Stryjewski; Francisco Nacinovich; Francesc Marco; Donald P Levine; Tom S Elliott; Claudio Q Fortes; Pilar Tornos; David L Gordon; Riccardo Utili; Francois Delahaye; G Ralph Corey; Vance G Fowler
Journal:  Clin Infect Dis       Date:  2008-01-15       Impact factor: 9.079

Review 4.  Endocarditis due to Staphylococcus lugdunensis: report of 11 cases and review.

Authors:  F Vandenesch; J Etienne; M E Reverdy; S J Eykyn
Journal:  Clin Infect Dis       Date:  1993-11       Impact factor: 9.079

Review 5.  Developments in outpatient parenteral antimicrobial therapy (OPAT) for Gram-positive infections in Europe, and the potential impact of daptomycin.

Authors:  Dilip Nathwani
Journal:  J Antimicrob Chemother       Date:  2009-07-07       Impact factor: 5.790

6.  Native valve endocarditis due to coagulase-negative staphylococci: report of 99 episodes from the International Collaboration on Endocarditis Merged Database.

Authors:  Vivian H Chu; Christopher H Cabell; Elias Abrutyn; G Ralph Corey; Bruno Hoen; Jose M Miro; Lars Olaison; Martin E Stryjewski; Paul Pappas; Kevin J Anstrom; Susannah Eykyn; Gilbert Habib; Natividad Benito; Vance G Fowler
Journal:  Clin Infect Dis       Date:  2004-10-27       Impact factor: 9.079

7.  Community-based outpatient parenteral antimicrobial therapy (CoPAT) for Staphylococcus aureus bacteraemia with or without infective endocarditis: analysis of the randomized trial comparing daptomycin with standard therapy.

Authors:  Susan Rehm; Marilyn Campion; David E Katz; Rene Russo; Helen W Boucher
Journal:  J Antimicrob Chemother       Date:  2009-03-05       Impact factor: 5.790

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.